Kamalahar

used in treatment of acute viral hepatitis; contains extracts of Tecoma undulata, Phyllanthus urinaria, Embelia ribes, Taraxacum officinale, Nyctanthes arbortistis, Terminalia arguna and Sodhit mineral salts

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1.

Hepatitis 10/01/1993 - "Kamalahar is an indigenous preparation reported to be beneficial in acute viral hepatitis. " 10/01/1993 - "Kamalahar offers therapeutic promise in acute viral hepatitis." 10/01/1993 - "Fifty two patients with acute viral hepatitis were randomized to receive either Kamalahar 500 mg or a matched placebo three times a day for 15 days. " 10/01/1993 - "A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis."